CliniSys has launched a new laboratory information management system for genomic laboratories in the UK. The company has brought GLIMS Genomics to the UK from Europe, where it is being successfully deployed at Poitiers University Hospital in France and will be introduced into seven additional laboratories in coming months.

Allscripts Healthcare Solutions (NASDAQ: MDRX) announced that Sunrise 20.0 is now generally available. Sunrise is a comprehensive platform of health that connects all aspects of care, including acute, ambulatory, surgical, pharmacy, radiology and laboratory services, and also features an integrated revenue cycle and patient administration system.

A major survey of NHS IT chiefs has revealed that despite more positive attitudes and uptake towards technology as a result of COVID-19, the long-term challenges of digital transformation within hospital trusts remain unchanged and only 14% of respondents believe they have sufficient funding to cover business priorities.

Hospital radio, interviews with iconic musicians, BBC archives and more than 600 healthcare information videos are among the services that patients will be able to access free of charge in hospitals that are signed up to WiFi services by WiFi SPARK. Hospital charities will also benefit from being supported on the SPARK Media platform, in a drive to help boost funds and raise awareness.

Siemens Healthineers and IBM Deutschland are introducing an open digital platform that will advance the networking of the German healthcare system and expand the infrastructure for the provision of digital services. Both partners are bringing their experience and expertise together for the project.

The Highland Marketing advisory board wanted to discuss how health and care organisations can make sure they are ready to implement technology and get the best use out of it. Who better to lead the discussion than James Freed, chief information officer for Health Education England?

OKRA, a Cambridge-based provider of Artificial Intelligence (AI) analytics for Life Sciences, has developed a new AI system to accurately predict the (a) price and (b) 'benefit outcome' of new drug molecules several years before launch. OKRA's system is the first of its kind and uses AI to deliver detailed evidence and reassurance to pharma professionals to aid the submission process, opening doors for more effective drugs to reach the market faster.